INVO Fertility Reports Unregistered Equity Sale
Ticker: IVF · Form: 8-K · Filed: Aug 1, 2025 · CIK: 1417926
| Field | Detail |
|---|---|
| Company | Invo Fertility, INC. (IVF) |
| Form Type | 8-K |
| Filed Date | Aug 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sale, equity-securities, company-name-change
TL;DR
INVO Fertility sold unregistered equity, check the details.
AI Summary
On July 28, 2025, INVO Fertility, Inc. filed an 8-K report detailing an unregistered sale of equity securities. The company, formerly known as NAYA Biosciences, Inc. and INVO Bioscience, Inc., is incorporated in Nevada and headquartered in Sarasota, Florida.
Why It Matters
This filing indicates a transaction involving the company's equity that was not registered with the SEC, which could have implications for investors regarding the terms and conditions of the sale.
Risk Assessment
Risk Level: medium — Unregistered sales of equity can sometimes indicate a need for capital or specific investor arrangements that may carry different risks than publicly registered offerings.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- INVO Bioscience, Inc. (company) — Former company name
- July 28, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Sarasota, FL (location) — Principal executive offices
FAQ
What type of equity securities were sold in the unregistered offering?
The filing does not specify the type of equity securities sold in the unregistered offering.
Who were the purchasers of the unregistered equity securities?
The filing does not disclose the identity of the purchasers of the unregistered equity securities.
What was the aggregate purchase price or total amount of the unregistered equity securities sold?
The filing does not provide details on the aggregate purchase price or total amount of the unregistered equity securities sold.
What is the purpose of this unregistered sale of equity securities?
The filing does not explicitly state the purpose behind the unregistered sale of equity securities.
Are there any specific exemptions from registration being relied upon for this sale?
While the filing indicates an unregistered sale, it does not explicitly cite the specific exemption from registration being relied upon.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 1, 2025 regarding INVO Fertility, Inc. (IVF).